Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma

Fig. 2

PD1+ EVs levels from different cell populations. Scatter plots with median showing PD1.+ EVs levels release from melanoma, T cells, B cells, monocytes and DCs as fold change of the first-response/basal and of the second-response/first-response or of the progression/response of NRES, long RES and RES > PRO MM patients. (*p < 0.05, **p < 0.01)

Back to article page